2019 Annual Meeting | Headache Neuromodulation Therapy

Date Wednesday 05/08/19

Time 01:00 PM - 01:45 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Hubs (Live Well)

Director(s) Heidi B. Schwarz, MD, F�鶹��ýӳ��

Topic(s) Experiential Learning Area, Headache

Learning Objectives Awareness of FDA approved neuromodulation devices for headache treatment, efficacy, safety and cost.

CME Available 0.75 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Didactic

Event Timeline
01:00 PM - 01:45 PM EDT	Speaker	Headache Neuromodulation Therapy Heidi B. Schwarz, MD, F�鶹��ýӳ��

Faculty Disclosures
Heidi B. Schwarz, MD, F�鶹��ýӳ��	Dr. Schwarz has received personal compensation for serving as an employee of University of Rochester Medical Center. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBSCO. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepost. Dr. Schwarz has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Law Firms.